3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
55
Ovarian Neoplasms
39
Carcinoma, Hepatocellular
39
Neoplasms
25
Fallopian Tube Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Endometrial Neoplasms
14
Glioblastoma
11
Breast Neoplasms
11
Brain Neoplasms
11
Colonic Neoplasms
10
Neoplasm Metastasis
9
Lung Neoplasms
8
Liver Neoplasms
8
Uterine Cervical Neoplasms
7
Stomach Neoplasms
6
Rectal Neoplasms
6
Glioma
6
Biliary Tract Neoplasms
6
Carcinoma, Ovarian Epithelial
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Small Cell Lung Carcinoma
3
Sarcoma
3
Recurrence
3
Peritoneal Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms, Nerve Tissue
3
Gastrointestinal Neoplasms
3
Interventions
Taxes
1
Standard of Care
1
Panitumumab
1
Pancreaticoduodenectomy
1
Optical Imaging
1
Losartan
1
Gemcitabine
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Adenocarcinoma
×
Bevacizumab
×
90 days
×
Clear all
No trials found.